Skip to content

Arrow Positive Placement Con/Epidural an

by Arrow Intl., Inc.

510(k) K801912

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

1 ongoing

This device is named in the recall

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK801912 Date16 Sep 1980ClearedStatusActive

Recalls

10 recalls · 1 ongoing · FDA

    • Ongoing Z-2364-2026 FDA Class I initiated 21 Apr 2026

    Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.

    • Terminated Z-2803-2020 FDA Class II initiated 6 Jul 2020

    The lidstock states the incorrect expiration date for the product. This issue could result in use of a device that is expired which could potentially lead to an increased risk of infection or other complications. Sterility, biocompatibility, safety, or efficacy of the kits and their components are not assured beyond the correct expiration date.

    • Terminated Z-1175-2020 FDA Class II initiated 15 Jan 2020

    There is the potential for various failures with the LOR (loss of resistance) syringes included in the kits resulting in dural puncture with some also requiring a blood patch.

  • 6 recalls, same reason

    • Terminated Z-1249-2020 FDA Class II initiated 20 Dec 2019
    • Terminated Z-1251-2020 FDA Class II initiated 20 Dec 2019
    • Terminated Z-1246-2020 FDA Class II initiated 20 Dec 2019
    • Terminated Z-1248-2020 FDA Class II initiated 20 Dec 2019
    • Terminated Z-1247-2020 FDA Class II initiated 20 Dec 2019
    • Terminated Z-1245-2020 FDA Class II initiated 20 Dec 2019

    Product lidstock contains the incorrect expiration date for the product

    • Terminated Z-2012-2018 FDA Class II initiated 11 Apr 2018

    Product sterility may be compromised due to unsealed packaging.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
CAZ
Device Class
Class II
Regulation
21 CFR Part 868.5140
Advisory Committee
Anesthesiology
FDA Decision
SESE Substantially Equivalent

Other devices from Arrow Intl., Inc.

See all devices from Arrow Intl., Inc. →